Infliximab for the treatment of metastatic hepatic and pulmonary Crohn's disease.
Gill
Kanwar R S
KR
Mahadevan
Uma
U
D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D003424:Crohn Disease / Q000150:complications / Q000188:drug therapy*; D005260:Female; D005765:Gastrointestinal Agents / Q000627:therapeutic use*; D006099:Granuloma / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D000069285:Infliximab; D008107:Liver Diseases / Q000188:drug therapy* / Q000209:etiology; D008171:Lung Diseases / Q000188:drug therapy* / Q000209:etiology; D016896:Treatment Outcome
D000911:Antibodies, Monoclonal; D005765:Gastrointestinal Agents; D000069285:Infliximab